Patents by Inventor Ronnie Ortiz

Ronnie Ortiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHIC FORMS OF A SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUND
    Publication number: 20220098186
    Abstract: Provided herein are novel crystalline forms of a crystalline compound of Formula (I), which modulates the ORL-1 receptor. The crystalline compounds of Formula (I), compositions thereof, and methods of using thereof that are described herein are particularly useful for treatment, prevention, and management of several sleep disorders.
    Type: Application
    Filed: January 30, 2020
    Publication date: March 31, 2022
    Applicant: Purdue Pharma L.P.
    Inventors: Ronnie ORTIZ, David IGO, Naoki TSUNO, Mayu FUKUDA, Naoki MIYAKE
  • METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE
    Publication number: 20170319712
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 9, 2017
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: RICHARD L. MILLER, MARK A. TOMAI, ROSS M. KEDL, ISIDRO ANGELO ELEAZAR ZARRAGA, RONNIE ORTIZ, JAMES D. STOESZ, PAUL D. WIGHTMAN
  • Methods and compositions for enhancing immune response
    Patent number: 9801947
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: October 31, 2017
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz, Paul D. Wightman
  • Sustained Release Composition Comprising an Amine as Active Agent and a Salt of a Cyclic Organic Acid
    Publication number: 20160051475
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.
    Type: Application
    Filed: September 11, 2015
    Publication date: February 25, 2016
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
  • DIETARY AND NUTRITIONAL SUPPLEMENTS CONTAINING AN OMEGA-3 FATTY ACID OF PLANT-BASED ORIGIN AND A FOLATE DERIVATIVE
    Publication number: 20150050261
    Abstract: The present invention relates to dietary and nutritional supplements comprising various vitamins, minerals and nutrients, including an omega-3 fatty acid of plant-based origin and a folate derivative.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 19, 2015
    Inventors: Chris G. Evenstad, Kelly M. Heimerl, Mike J. McBride, Ronnie Ortiz, Carrol J. Rhead, Sami Yusuf, Michelle B. Zachman
  • METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE
    Publication number: 20150044279
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: October 6, 2014
    Publication date: February 12, 2015
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz, Paul D. Wightman
  • SUSTAINED RELEASE COMPOSITION COMPRISING AN AMINE AS ACTIVE AGENT AND A SALT OF A CYCLIC ORGANIC ACID
    Publication number: 20130237559
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.
    Type: Application
    Filed: June 29, 2011
    Publication date: September 12, 2013
    Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
  • FORMULATION FOR DELIVERY OF IMMUNE RESPONSE MODIFIERS
    Publication number: 20100028381
    Abstract: The present invention provides pharmaceutical compositions that include an IRM-PEG complex and an antigen, formulated together in a thermoresponsive gel. In another aspect, the present invention also provides a method of eliciting an antigen-specific immune response in a subject. Generally, the method includes administering to the subject a pharmaceutical composition comprising an IRM-PEG complex and an antigen, formulated together in a thermoresponsive gel, in an amount effective to generate an immune response in the subject against the antigen. In yet another aspect, the present invention also provides a method of treating a condition in a subject. Generally, the method includes administering to the subject a pharmaceutical composition comprising an IRM-PEG complex and an antigen, formulated together in a thermoresponsive gel, in an amount effective to ameliorate at least one symptom or clinical sign of the condition.
    Type: Application
    Filed: June 18, 2007
    Publication date: February 4, 2010
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Kevin S. Gorski, Ronnie Ortiz, James D. Stoesz, Isidro Angelo E. Zarraga
  • Methods and compositions for enhancing immune response
    Publication number: 20040265351
    Abstract: Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 30, 2004
    Inventors: Richard L. Miller, Mark A. Tomai, Ross M. Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D. Stoesz